Discovery of an orally active series of isoxazoline glycoprotein IIb/IIIa antagonists

被引：79

作者：

Xue, CB ^{[1
]}

Wityak, J ^{[1
]}

Sielecki, TM ^{[1
]}

Pinto, DJ ^{[1
]}

Batt, DG ^{[1
]}

Cain, GA ^{[1
]}

Sworin, M ^{[1
]}

Rockwell, AL ^{[1
]}

Roderick, JJ ^{[1
]}

Wang, SG ^{[1
]}

Orwat, MJ ^{[1
]}

Frietze, WE ^{[1
]}

Bostrom, LL ^{[1
]}

Liu, J ^{[1
]}

Higley, CA ^{[1
]}

Rankin, FW ^{[1
]}

Tobin, AE ^{[1
]}

Emmett, G ^{[1
]}

Lalka, GK ^{[1
]}

Sze, JY ^{[1
]}

DiMeo, SV ^{[1
]}

Mousa, SA ^{[1
]}

Thoolen, MJ ^{[1
]}

Racanelli, AL ^{[1
]}

Hausner, EA ^{[1
]}

Reilly, TM ^{[1
]}

DeGrado, WF ^{[1
]}

Wexler, RR ^{[1
]}

Olson, RE ^{[1
]}

机构：

[1] DUPONT MERCK PHARMACEUT CO,WILMINGTON,DE 19880

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1997年 / 40卷 / 13期

关键词：

D O I：

10.1021/jm960799i

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Using isoxazoline XR299 (1a) as a starting point for the design of highly potent, long-duration GPIIb/IIIa antagonists, the effect of placing lipophilic substituents at positions alpha and beta to the carboxylate moiety was evaluated. Of the compounds studied, it was found that the n-butyl carbamate 24u(1,2) exhibited superior potency and, duration of ex vivo antiplatelet effects in dogs. Replacement of the benzamidin-4-yl moiety with alternative basic groups, elimination of the isoxazoline stereocenter, and reversal of the orientation of the isoxazoline ring resulted in lowered potency and/or duration of action.

引用

页码：2064 / 2084

页数：21

共 56 条

[51]

WAGNER G, 1981, PHARMAZIE, V36, P597

[52] Discovery of potent isoxazoline glycoprotein IIb/IIIa receptor antagonists [J].

Wityak, J ;

Sielecki, TM ;

Pinto, DJ ;

Emmett, G ;

Sze, JY ;

Liu, J ;

Tobin, AE ;

Wang, SA ;

Jiang, B ;

Ma, P ;

Mousa, SA ;

Wexler, RR ;

Olson, RE .

JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (01) :50-60

[53] Design, synthesis and in vitro activities of a series of benzimidazole/benzoxazole glycoprotein IIb/IIIa inhibitors [J].

Xue, CB ;

Rafalski, M ;

Roderick, J ;

Eyermann, CJ ;

Mousa, S ;

Olson, RE ;

DeGrado, WF .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (03) :339-344

[54]

XUE CB, 1996, 211 AM CHEM SOC NAT

[55] POTENT IN-VITRO AND IN-VIVO INHIBITORS OF PLATELET-AGGREGATION BASED UPON THE ARG-GLY-ASP-PHE SEQUENCE OF FIBRINOGEN - A PROPOSAL ON THE NATURE OF THE BINDING INTERACTION BETWEEN THE ARG-GUANIDINE OF RGDX MIMETICS AND THE PLATELET GP IIB-IIIA RECEPTOR [J].

ZABLOCKI, JA ;

MIYANO, M ;

GARLAND, RB ;

PIREH, D ;

SCHRETZMAN, L ;

RAO, SN ;

LINDMARK, RJ ;

PANZERKNODLE, SG ;

NICHOLSON, NS ;

TAITE, BB ;

SALYERS, AK ;

KING, LW ;

CAMPION, JG ;

FEIGEN, LP .

JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (13) :1811-1819

[56] A NOVEL SERIES OF ORALLY-ACTIVE ANTIPLATELET AGENTS [J].

ZABLOCKI, JA ;

TJOENG, FS ;

BOVY, PR ;

MIYANO, M ;

GARLAND, RB ;

WILLIAMS, K ;

SCHRETZMAN, L ;

ZUPEC, ME ;

RICO, JG ;

LINDMARK, RJ ;

TOTH, MV ;

MCMACKINS, DE ;

ADAMS, SP ;